Asher Fawwad

Asher Fawwad


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
EAEraj Abbas
Eraj Abbas
AFAsher Fawwad
Asher Fawwad
ISIftikhar Ahmed Siddiqui
Iftikhar Ahmed Siddiqui
MAMuhammad Sohail Afzal
Muhammad Sohail Afzal
MAMuhammad Ansar
Muhammad Ansar
Syed M. ShahidSyed M. Shahid
Syed M. Shahid
Background/Objective: Early-onset diabetes (EOD), diagnosed at ≤35 years, is a growing public health crisis in low- and middle-income countries, including Pakistan. Identifying modifiable and non-modifiable risk factors is critical for developing effective prevention strategies. This study aimed to investigate the risk factors associated with EOD in Sindh, Pakistan, focusing on genetic, lifestyle, and metabolic determinants. Methods: A multicenter cross-sectional study was conducted across diabetic clinics in Sindh, with primary data collection at Baqai Institute of Diabetology and Endocrinology (Karachi, Pakistan) and secondary sites in Hyderabad, Larkana, and Sukkur. Following institutional ethical approval and informed consent, we enrolled 754 individuals (type 1 and type 2 diabetes, age at diagnosis: 15–35 years). Data on anthropometric, clinical, biochemical, and lifestyle parameters were collected via structured questionnaires. Statistical analyses included Pearson’s Chi Square tests and multivariate logistic regression in determining associations. Results: Logistic regression revealed key predictors of early-onset diabetes (EOD). A two-generation diabetes family history showed a strong association (aOR:1.86, 1.12–3.43). Significant lifestyle risks included physical inactivity (OR:1.40, 1.03–1.90), frequent sugary beverage intake (OR:1.93, 1.89–1.98), and abnormal sleep duration (8 h: OR:1.86, 1.21–2.85). Hypertension was a major metabolic predictor (elevated BP: OR:1.79, 1.28–1.54; Stage I: OR:1.81, 1.34–1.77). Cardiovascular disease and uncontrolled fasting glucose lost significance after adjustment, indicating confounding effects. Conclusions: This study highlights familial predisposition, sedentary behavior, poor diet, sleep disturbances, and hypertension as key contributors to EOD in young Pakistani adults. Early screening and targeted lifestyle interventions are urgently needed to mitigate this escalating epidemic.

10 March 2025 in Anaesthesia, Pain & Intensive Care
Verified
Journal Article
Open access
PDF file
SRSaima Rehman
Saima Rehman
QAQamer Aziz
Qamer Aziz
IAIffat Ara Aziz
Iffat Ara Aziz
RNRuqaya nangrejo
Ruqaya nangrejo
IAIftikhar Ahmed
Iftikhar Ahmed
AFAsher Fawwad
Asher Fawwad
Background & objective: Recent research has identified various biomarkers in metabolic diseases, which can indicate the severity and the outcome of the disease. This study aimed to compare serum Apelin levels between obese and non-obese patients with type 2 diabetes mellitus (T2DM) and investigate their relationship with obesity and cardio-metabolic indicators. By analyzing these connections, the study attempted to clarify Apelin’s role in obesity-related cardio-metabolic risks and its potential as a biomarker for better T2DM management. Methodology: This cross-sectional study included a total of 200 patients, divided into two groups: 100 obese and 100 non-obese T2DM patients, and their anthropometric and clinical data, including weight, body mass index (BMI), waist and hip circumferences (WC and HC), and blood pressure, were collected. We measured serum Apelin, fasting blood sugar (FBS), hemoglobin A1C (HbA1c), and lipid profile, and analyzed correlations between Apelin levels with the study parameters. Results: Serum Apelin levels were significantly higher in obese T2DM patients compared to non-obese T2DM patients (P < 0.000). Apelin levels exhibited a positive but weak correlation with weight (r = 0.150), BMI (r = 0.384), WC (r = 0.331), and HC (r = 0.422). Diastolic blood pressure showed an average positive correlation with Apelin (r = 0.224). FBS levels were negatively correlated with Apelin (r = -0.214, P < 0.0001) while HbA1c and serum Apelin had a weak and statistically insignificant correlation (r = 0.064). Serum total cholesterol TC (r = 0.194) and triglycerides TG (r = 0.146) had weak positive correlations with Apelin, while High-Density Lipoproteins (HDL) exhibited a significant, negative correlation (r = -0.253). Conclusion: Elevated serum Apelin levels observed in obese T2DM patients indicate a potential compensatory mechanism in response to obesity-related complications. Further studies are warranted to elucidate the exact role of Apelin in the pathophysiology of T2DM, particularly in the context of obesity. Abbreviations: BMI: Body Mass Index, T2DM: type 2 diabetes mellitus, FBS: fasting blood sugar, HDL: High-Density Lipoproteins, HC: hip circumference, WC: waist circumference Keywords: Apelin; Diabetes Mellitus; Obesity; Cardiometabolic risks; Pakistan Citation: Rehman S, Aziz Q, Aziz IA, Nangrejo R, Ahmed I, Fawwad A. Comparative analysis of apelin levels in type 2 diabetes mellitus among the obese and non-obese population of Karachi, Pakistan. Anaesth. pain intensive care 2025;29(7):719-726. DOI: 10.35975/apic.v29i7.2966 Received: May 09, 2025; Revised: October 26, 2024; Accepted: January 01, 2025

1 October 2023 in Journal of Diabetology
Verified
Journal Article
Open access
AFAsher Fawwad
Asher Fawwad
KBKhalid Abdul Basit
Khalid Abdul Basit
AZAwn Bin Zafar
Awn Bin Zafar
BTBilal Tahir
Bilal Tahir
MAMaria Anwar
Maria Anwar
ABAbdul Basit
Abdul Basit
Objective: To assess the effect of a single-dose, oral vitamin D supplementation (soft gel capsule of 200,000 IU) in subjects with painful diabetic neuropathy (PDN) in Pakistan. Design: Randomized control trial. Materials and Methods: This randomized control trial was conducted at the Baqai Institute of Diabetology and Endocrinology (BIDE), Pakistan from November 2021 to August 2022. Subjects with diabetes without any signs of vitamin D deficiency were included. Baseline details were obtained by a predesigned questionnaire. Douleur neuropathy 4 (DN4) score was used for diagnosing PDN. Biochemical tests include serum 25-hydroxyvitamin D (OH)D and HbA1c for screening at baseline and at 3 months follow-up were analyzed. Subjects were categorized into two: a control group and an intervention group. The intervention group was given a single soft gel vitamin D capsule (200,000 IU) after screening by expert paramedical staff. Based on baseline serum vitamin D levels, the intervention group was further categorized into insufficient vs. deficient groups, and the control group was categorized into insufficient vs. sufficient. Results: Of 159 participants, 19.5% vs. 44.7% subjects were with insufficient vs. deficient vitamin D levels in the intervention group, and 10.7% vs. 25.1% were with insufficient vs. sufficient vitamin D levels in the control group, respectively. Though the findings are insignificant, DN4 score at follow-up in intervention groups and control groups was reduced compared to the baseline DN4 score. Furthermore, we observed a reduction in post-HbA1c levels in both the intervention groups (insufficient vs. deficient) and the control-sufficient group. Conclusion: Treatment with vitamin D supplementation in people with PDN helps to improve vitamin D levels, DN4 score, and HbA1c levels, though dose-response is yet to be compared.

27 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
RARahima Aftab
Rahima Aftab
AFAsher Fawwad
Asher Fawwad
EAEraj Abbas
Eraj Abbas
RNRuqaya nangrejo
Ruqaya nangrejo
FFFasiha Fatima
Fasiha Fatima
Syed M. ShahidSyed M. Shahid
Syed M. Shahid
Background/Objectives: The rising global burden of type 2 diabetes mellitus (T2DM) demands multifaceted and more effective treatment strategies beyond monotherapy to achieve optimal metabolic control. The study aimed to evaluate the integrated effects of SGLT2 inhibitors and metformin in newly diagnosed T2DM patients on biochemical parameters, clinical outcomes and hormonal changes. Methods: This prospective longitudinal study was conducted at the Department of Biochemistry, Baqai Medical University, in collaboration with the Baqai Institute of Diabetology and Endocrinology. A total of 120 newly diagnosed T2DM patients were enrolled and stratified into three groups (n = 40): Group 1 (SGLT2 inhibitors only), Group 2 (SGLT2 inhibitors + metformin), and Group 3 (metformin only). Patients were followed for six months with data collection at baseline, at 3 months and 6 months. Anthropometric indices (weight, BMI, waist and hip circumferences, WHR), biochemical markers (FBS, HbA1c, lipid profile, uric acid, serum creatinine, HOMA-IR), and hormonal levels (insulin, glucagon) were assessed at baseline, first follow-up, and second follow-up. ANOVA, post hoc, Bonferroni and Tukey’s tests were applied; p-value < 0.05 was considered significant. Results: The findings indicate that Group 2 showed the greatest improvement in anthropometric parameters, particularly waist and hip circumferences (p < 0.01). Group 3 demonstrated the most significant improvement in glycemic indices and lipid profile (p < 0.01). HOMA-IR significantly decreased in Group 3 from baseline to the first follow-up (p < 0.01). While insulin levels remain insignificantly different among all groups. Glucagon levels declined significantly from baseline to the second follow-up in all groups, with a more pronounced decrease in Group 3 (p < 0.01). Serum creatinine and uric acid levels showed significant reductions from baseline to the second follow-up in Group 1 and Group 2 (p < 0.05). However, given the observational design, these associations should not be interpreted as causal evidence of renoprotection. Conclusions: Within the limitations of this observational study, early differences among treatment regimens were observed, though metabolic outcomes became statistically comparable across groups by six months. These hypothesis-generating findings suggest potential benefits of early combination therapy that require confirmation in randomized controlled trials. Given the substantial within-group variability and non-randomized design, no definitive conclusions about therapeutic associations can be drawn from these data.

1 October 2021 in Journal of Diabetology
Verified
Journal Article
Open access
AFAsher Fawwad
Asher Fawwad
NMNida Mustafa
Nida Mustafa
NWNazish Waris
Nazish Waris
SASaima Askari
Saima Askari
ABAbdul Basit
Abdul Basit
Aim: The aim of this article is to determine knowledge level and perception about coronavirus disease 2019 (COVID-19) among people with diabetes. Materials and Methods: A cross-sectional study was conducted among 268 diabetic subjects from April 2020 to October 2020 at the outpatient department of Baqai Institute of Diabetology and Endocrinology, Karachi, Pakistan. A series of questions regarding knowledge and perception about COVID-19 were asked, and participants’ demographic characteristics and source of information regarding COVID-19 were recorded and analyzed. Results: Among 268 participants, 59.7% had diabetes for more than 5 years. More than half of the subjects had heard about COVID-19 on television (63.8%). The majority of subjects had information about symptoms of COVID-19, including fever (92.2%), dry cough (79.9%), flu (78%), and shortness of breath (52.6%). Most of the participants had knowledge about preventive measures for COVID-19 such as wearing a face mask (77.6%), washing hands frequently with soap (72.8%), using hand sanitizer (72%), social distancing (47.4%), isolation and hygiene (38.8%), and quarantining (32.1%). However, less than half of the participants knew the correct meanings of social distancing (40.3%), isolation (29.1%), and quarantine (22.4%). Conclusion: Overall, most of the participants had information about common symptoms of COVID-19 including fever, dry cough, flu, and shortness of breath as they had heard about COVID-19 on television, at office, radio, and their living area. The government has taken effective measures in the prevention of COVID-19. Still, there remains a need for public awareness campaigns to combat the spread of disease.